Oragenics, a clinical-stage biopharmaceutical company, received approval from NYSE Regulation for its compliance plan, allowing it to maintain its NYSE American listing through February 25, 2028. This extension follows the company's reported low stockholders' equity and losses over recent years. The approval enables Oragenics to continue its strategic initiatives and capital raising efforts while working to regain full compliance. The company is focused on advancing its neurological therapeutic ONP-002, though clinical trials are currently paused due to device stability and funding challenges.
Oragenics' recent NYSE American compliance plan approval provides context for health sector market activity. For readers following health stocks, here is Pluang's market snapshot as of Nov 13, 2026 04:11 WIB: out of 150 priced health-sector US stocks tradable on Pluang, 23 rose and 124 fell. Notable movers include ClearPoint Neuro Inc (CLPT) at USD 8.46 with a 1-day change of -7.74% and 100% sell order activity, Nuwellis Inc (NUWE) at USD 5.11 down 7.59% with 100% sell orders, and Moderna, Inc. (MRNA) at USD 230.95 down 7.13% with 58% sell orders and 42% buy orders. Typical hold times range from 13 to 58 days among these stocks.
ASUS has introduced a broad ecosystem of AI-ready hardware and software designed for gamers, creators, developers, and enterprises. The ASUS Agent Computer initiative enables users to deploy AI locally, in the cloud, or via hybrid models, offering co...
The global cosmetic peptide synthesis market is projected to grow from $274 million in 2027 to $354.85 million by 2032, with a CAGR of 5.34%. Growth is fueled by rising demand for advanced anti-aging skincare ingredients, increased use of peptide-bas...
Cisco is set to report its fiscal Q1 2027 earnings with a focus on cloud growth and AI demand. Analysts expect revenue around $18.1 billion, operating income of $6.5 billion, and earnings per share of $1.33, reflecting strong year-over-year growth. T...
BASF has agreed to sell its global mining solutions business to SNF, a specialty chemical company based in France, following a strategic review of BASF's Performance Chemicals division. The deal includes BASF's mining chemicals portfolio, production ...
TDG Gold Corp. has agreed to sell a 51% interest in its Aurora West property to Freeport-McMoRan for C$110 million in cash. Freeport also has an option to increase its ownership to 75% or 100% by funding an additional C$80 million in exploration and ...
